Home » Lack of Incentives, Poor Diagnoses Limit Orphan Drug Access in China, India
Lack of Incentives, Poor Diagnoses Limit Orphan Drug Access in China, India
May 10, 2012
Patients with rare diseases in rural China and India are finding it increasingly difficult to obtain necessary medications, and both countries need to find ways to increase access to orphan drugs, experts say.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor